Apply now for one of next year’s EAN Clinical Fellowships - get experience in a host department outside your country of residency, under recognised experts.

As part of the EAN Scientific Committee’s liaison with the European Medicines Agency, we reviewed their 2024 Annual Report to identify developments of relevance to the field of neurology.

The winners of the Brain Health School Challenge: Finland 2025 were announced at a celebratory event held at Helsinki City Hall, where the remarkable efforts of students from across the country were recognised.

Teacher of the sixth-grade class at 1st Experimental Primary School of Thessaloniki, describes their inspiring journey through the Brain Health School Challenge.

At the EAN Congress 2025 in Helsinki, the EAN celebrated the successful completion of the second CoCoCare cohort and welcomed a new class.

Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

The EAN Regional Teaching Session (RTS) titled Unlocking Genetic Clues in Neurological Disorders will be held on 15 December, during the Annual Meeting of the Turkish Neurological Society in Antalya, Türkiye.

The Career Development Session on AI at EAN 2025 featured three talks covering the breadth of current applications: in the clinic, in research, and in neuroradiology.

The European Huntington Association is thrilled to announce its 5th Biennial Conference, in Bucharest, Romania, on 25–28 September. Under the theme “Shaping our Future Together, We are the Change!”

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for July 2025.

EAN President, Elena Moro looks back at the 11th Congress of the European Academy of Neurology, which took place in Helsinki on 21-24 June.

Welcome to the July 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

This study presents the findings of a systematic review and a collaborative individual patient data meta-analysis of clinical trials involving patients with acute ischaemic stroke and atrial fibrillation, who were treated with either early or delayed initiation of DOACs at approved dosages.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.